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Abstract Folliculogenesis is a cycle that produces the major-
ity of oocyte. Any disruption to this cycle leads to ovulation
diseases, like polycystic ovarian syndrome (PCOS).
Treatments include drugs and surgery; lasers have also been
used complementarily. Meanwhile, still there is no definite
treatment for PCOS. This study investigated the photo-bio
stimulation effect of near-infrared and red low-level laser on
producing follicles and compared the result with result of
using common drug, clomiphene. Therefore, the aim of this
study was to propose the use of lasers autonomously treat-
ment. So, there was one question: how do lasers affect
folliculogenesis cycle in rat’s ovary tissue? In this study, 28
rats were assigned to four groups as follows: control (CT),
clomiphene drug (D), red laser (RL), and near-infrared laser
(NIRL). Afterwards, 14 rats of RL and NIRL groups received
laser on the first 2 days of estrous cycle, each 6 days, for
48 days. During treatment period, each rat received energy
density of 5 J/cm2. Seven rats in D group received clomiphene.
After the experiment, lasers’ effects at two wavelengths of 630
and 810 nm groups have been investigated and compared with
clomiphene and CT groups. Producing different follicles to
complement folliculogenesis cycle increased in NIRL and RL
groups, but this increase was significant only in the NIRL
group. This indicates that NIRL increases ovarian activity to
produce oocyte that certainly can be used in future studies for
finding a cure to ovarian negligence to produce more oocyte
and treat diseases caused by it like PCOS.
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Introduction
Folliculogenesis is a cycle in which primordial follicles grow
and produce graffian follicles in several stages and eventually
produce the majority of oocyte [1]. Primordial follicles are
embryonic [2] since there were a million of them resting fol-
licle in every woman’s body at birth [3]. So, before puberty,
mammalian ovary contains these follicles [4]. There are a lot
of non-growing primordial follicles in their ovary (oocytes
surrounded by flattened pre-granulosa cells) [5] most of which
remain until puberty; then, they may either degenerate or ac-
tivate and grow towards primary, secondary, tertiary, and qua-
ternary stages (with an antral cavity) [6]. Following activation,
primordial follicles develop and give rise to primary follicles
(i) and then secondary follicles (ii). Next, by the stimulation of
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gonadotropin (FSH and luteinizing hormone (LH)), multi-
layered antral follicles containing antral cavities are produced
(iii); in the last stage, granulosa cells are demarcated and cause
a single large antral cavity to be formed and the oocyte, ready
for ovulation, reaches its final growth in the graffian follicle
(iv); in other words, folliculogenesis cycle is completed [1, 7,
8]. Disorder in folliculogenesis cycle causes several diseases;
polycystic ovarian syndrome (PCOS) is an important one [9].
In the reproductive age, 5 to 10% of reproductive age woman
with PCOS are infertile [10, 11]. Search for a definite treat-
ment of PCOS started in the early 1930s and still continues
[11, 12]. The available modalities for induction of ovulation
are weight reduction, clomiphene citrate, gonadotropin thera-
py, insulin sensitizer as metformin, and finally, ovarian dril-
ling using laser or bipolar diathermy. Despite these treatment
modalities, there are still cases resistant to treatment; this
raises the need for a new treatment method [9, 13–15].
Different lasers can be used for PCOS drilling including
argon, KTP, ND:YAG, and CO2. All of these stimulate ovary
to increase activation of folliculogenesis cycle to ovulation.
Lasers are also used to treat ovarian malignant and cancer [16,
17–19]. Degrees of response are variable [9].
Lasers have already been used as complement therapies,
applied with medication or surgery, but they are also effective
for ovarian stimulation [11, 16, 17, 20]. The direct effect of
lasers, alone, on folliculogenesis cycle has not been investi-
gated. So, the purpose of this study is to investigate the effect
of lasers without surgery or drug on folliculogenesis cycle.
Method and materials
Animals
Initially, 28 female Wistar rats which have reached sex-
ual maturity, with the average age of 9 weeks and in
weight range of 150–300 g, were obtained from ani-
mal’s house of Tabriz University of Medical sciences
(TUMS), Medical Physics Department. Then, rats’ gen-
eral health was examined by estrous test in order to be
in the same phase of menstrual cycle. They were ran-
domly assigned to four groups (n = 7): control group
(CT), without any intervention; clomiphene drug group
(D), stimulated by clomiphene; red laser group (RL),
stimulated by visible laser in red spectrum; and near-
infrared laser (NIRL), stimulated by laser in the near-
infrared spectrum. Afterwards, they were taken care of
for 1 week on environmental conditions with free access
to food and water; temperature (25–27 °C) and humidity
were kept steady so that the rats would adapt to condi-
tions of the new place. After a week, rats were weighed
to ensure they remain in the range. Their behavior in
the cage was examined during the experiment. The
research protocol of this study was approved by Ethics
in Research Committee of Tabriz University ofMedical Sciences
TUMS, under code number: TBZMED.REC.1394.238.
Preparation process
Rats were painted for each group and labeled from one to
seven. Then, their hairs in RL and NIRL groups were shaved
and then the shaved areas were washed using Betadine. The
point for laser radiation on their skin was determined and
marked by marker. During the experiment, rats were in their
own cages, expecting intervention or box cleaning (three
times per week). Intervention on rats was done at the begin-
ning of menstrual cycle. The preparation method in this study
was designed based on references [9, 11, 20–25].
Laser treatment
Fourteen rats of RL and NIRL groups received laser on the first
2 days of estrous cycle on specified times (each 6 days, for
48 days). Before doing the experiment, dose transfer percent
and irradiation time were determined by a primary experiment.
The probes were done by two diode lasers (MUSTANG 2000
+, Moscow, Russia), 630 and 810 nm, by 33 ± 2 and 212 ± 2
power output with 10 mm diameter of nuzzle for both probes,
the laser beam area was 0.79 cm2, and power densities were
41.77 mw/cm2 for red laser and 268.35 mw/cm2 for NIR laser
beams. Continuous pulse laser mode has been found to be
optimal for increasing the activity of protein, ATP synthesis,
and cell growth [21, 23]. Irradiation was done for 142.2 and
28 s for RL and NIRL groups, respectively. The laser probes
were placed directly on the marked part of the skin with per-
pendicular angle (Fig. 1a). Henceforth, the same dose of laser
was transferred on ovary for two groups; however, the percent-
age of transferred dose and irradiation time was already deter-
mined by a primary experiment. Water was used to provide
coupling media for matching impedance between the laser
probe and skin of rats. During the treatment, they were fixed
in a Plexiglas restrainer designed for this study (Fig. 1b). The
average dose reaching the target was 5 J/cm2 that was found to
be optimal for increasing the activity of protein, ATP synthesis,
and cell growth [21]. In this study, we introduced the irradiated
time for two groups, red and infrared by calculating average
dose to be sure how much the average dose has been reached
the target. Transcranial low-level laser therapy (LLLT) treat-
ment was done 16 times in 8 weeks. Also, the marked skin area
thickness was measured to calculate skin attenuation coefficient
by Lambert-Beer equation.
I ¼ I0e−μx ð1Þ
μx ¼ lnI0
I
ð2Þ
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Clomiphene treatment
Seven rats in D group received clomiphene drug. This drug
can stimulate folliculogenesis cycle and increase sex hormone
activation and consequently increase fertility [26]. The applied
dose was 1 μg/kg in 1 cm3 water solution. They received drug
when RL and NIRL groups were undergoing irradiation. It
was determined based on previously published protocol about
clomiphene application [26].
Treatment process
Except for the treatments, all conditions were similar for all
rats.
After the experiment, rats were weighted again. After an
overnight food deprivation, each animal was anesthetized
with an intraperitoneal injection of ketamine/xylazine (60/
10 mg/kg). Its blood serum was derived, and the ovary was
immediately removed and rinsed in a cold saline and weighed.
The ovary tissue was divided into two parts: one parts was
frozen by liquid nitrogen and stored in −80 °C refrigerator
until the biochemical assay and the other part was immersed
in 10% formalin, dehydrated in ethanol, cleared in xylene, and
embedded in paraffin for histopathological evaluations. After
tissue processing steps, several serial sections of ovary (5 μm
thicknesses) were prepared and stained by hematoxylin and
eosin (H&E) for microscopic observations and studies. The
thickness of media tunica was measured using Motic Images
version 2.0 and light microscope. The stained sections were
anonymously evaluated by a histologist, see also [27].
The samples were evaluated and analyzed with the statisti-
cal, SPSS software. The significance of the data was deter-
mined and table and chart were drawn, accordingly.
Blood serum measurement
Blood samples were taken by cardiac puncher and centrifuged
(AZMA Co., Iran-Pars) at 3600 rpm at room temperature for
10 min. Then, they were stored at −80 °C until the assay. They
were transferred to veterinary clinic (Dr MUSAVI CLINICE,
TABRIZ, IRAN, Dr. Eshrat Khah et al.) for sex hormone
measurements. The kit (LH ELISA KIT, FSH ELISA KIT,
E2 AccuBind ELISA, and Progesterone AccuBind ELISA-
Pishtaz Teb-Iran) is used for counting the amount of hor-
mones, LH, FSH, estrogen, and progesterone, which influence
folliculogenesis cycle to ovulation [28–33].
Laser beam transmission measurement
Ovary and skin samples were taken and data were analyzed by
a statistical program. Also, attenuation coefficient was calcu-
lated by Lambert-Beer law. By using that, laser absorption has
been carried out to a percentage reaching potential that ovaries
were calculated. Each data was obtained by three repetitions.
They were compared with the standard information. Skin
thickness was measured by a standard caliper (Pittsburgh 6-
in. digital caliper with 0.03 mm precision).
Statistical analysis
The number of different follicles and blood hormone levels,
LH, FSH, estrogen, and progesterone was statistically ana-
lyzed by the IBM SPSS statistics 19 software.
Once, Tukey’s HSD test and, another time, analysis of var-
iance (ANOVA Post Hot) were used. All data were reported as
mean ± SD. Significance level was set at P < 0.05.
Result
For histological investigations, changes in the primary, multi-
laminar, secondary, and graffian follicles were studied and for
hormonal investigations, follicle stimulation hormones, lu-
teinizing, estrogen, and progesterone hormones were taken
into consideration.
Fig. 1 a Laser irradiation: This
image shows style of laser
irradiation during the experiment.
b Rat restrainer: this restrainer
designed for this study. It is
approved by Ethics and Research
Committee of TUMS (code
number:
TBZMED.REC.1394.238)
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Histological investigations
Primary follicle
The number of PF increased significantly in RL and NIRL
groups, compared with CT and D groups. This increase was
equal in the RL and NIRL groups (Fig. 2a), and hence, the
difference between these two groupswas not significant. Also,
there was an increase in D group but this growth was less than
RL and NIRL groups and did not differ significantly from the
CT (Table 1). As can be inferred from the table, increase in the
follicle of RL and NIRL groups was approximately 2.02 times
more than the D group (Fig. 3).
So, the increase in the samples of separate groups can be
written as
CT < D < RL ¼ NIRL
Primary multi-laminar follicles
The results of primary multi-laminar follicles (PFM) were
similar to PF analysis (Table 1); the only difference was that
the growth ratios in RL an NIRL were not equal. PFM in-
crease in NIRL was approximately 1.46 times more than D
and 1.09 times more than RL compared with CT group
(Fig. 3). This result has been obtained according to Table 1,
and the ascending range of the PFM can be seen in the chart.
The highest value was for NIRL group. However, there was
not much difference between RL and NIRL while both of
them were more than D group, compared with CT (Fig. 2b).
According to the chart, the relationship between the separate
groups is as
CT < D < RL < NIRL
Secondary follicles
Counting secondary follicles (SF) showed that their number
increased significantly in both RL and NIRL groups, com-
pared with CT, while there was not a significant relationship
difference between RL andNIRL (Fig. 3). Comparedwith CT,
the increasing rate in NIRL was approximately 1.38 times
more than RL and 2.10 times more than D. However, there
was no significant difference between D and CTor between D
and RL but the difference between D and NIRL was signifi-
cant (Table 1). The SF production increased almost linearly,
with NIRL producing them the most (Fig. 2c).
So, the ordering of groups with respect the number of SF is as
CT < D < RL < NIRL
Graffian follicles
The increase in graffian follicles (GF) differed significantly
between the CT and RL and between CT and NIRL.
Contrary to PF, PFM, and SF results, the difference between
RL and NIRL was significant. Also, there was no significant
difference between CT and D group, as in other types of fol-
licles. Compared with CT, the increased proportion of GF in
NIRL was approximately 2.50 times more than D group and
1.95 times more than RL (Fig. 3). The GF production had an
ascending range, like SF and PFM. NIRL samples had max-
imum amounts and CTsamples had minimum amounts. NIRL
and RL had increased compared to D and CT. Although there
was not much difference between D and RL samples (Fig. 2d),
the relationship can be written as
CT < D < RL < NIRL
Fig. 2 Number of different follicles. a PF increase in two RL and NIRL
group with equal ratio compared to D and CT group. b Increase ratio for
PFM is not equal. There is little difference in increase ratio for NIRL and
RL group compared with CT and D group apposite of PF number. c The
changes of SF. It increases in NIRL group more than the other group. d
The changes of GF. It increases by laser and drug intervention too, but
there is not little difference between D and RL group opposites of NIRL.
NIRL has the most increase in the number of GF
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Hormonal investigations
Follicle stimulation hormone
The level of FSH production has increased in the three
experimental groups compared with CT (Fig. 4a).
According to the chart, growth in D samples was not much
different from CT and there was a large difference between
D and IRL. Compared to CT group, NIRL increased ap-
proximately 2.73 times more than RL and 25.29 times
more than D. On the other hand, the increase of FSH
differed significantly between D and RL and between D
and IRL groups. This increase was the most for NIRL.
Also, RL and the other groups differed significantly
(Table 2). According to the table, the growth rate of FSH
can be written as
NIRL > RL > D > CT
Luteinizing hormone
Increase in the level of luteinizing hormone (LH) differed
significantly between CT and D and between CT and RL.
But while LH increased in the NIRL, it was not significantly
different from CT. Compared to CT group, RL increased LH
approximately 1.50 times more than D and 6.44 times more
than NIRL. Significant differences existed between D and
NIRL and between RL and NIRL, while there was no signif-
icant difference between RL and D groups (Table 2). The
Table 1 Histopathological
parameter in ovary tissue Parameters CT D RL NIRL
PF 0.75 ± 0.250 1.29 ± 0.286 2.60 ± 0.245* 2.60 ± 0.600*
PFM 1.33 ± 0.667 2.40 ± 0.400 3.20 ± 0.200* 3.50 ± 0.289*
SF 0.50 ± 0.500 1.43 ± 0.202 2.17 ± 0.307* 3.00 ± 0.408*,**
GF 0.67 ± 0.333 2.00 ± 0.447 2.57 ± 0.202* 5.00 ± 0.548*,**,***
Data are presented as mean ± SD
C control, D clomiphene drug, RL red laser injection, NIRL near-infrared laser injection
*P < 0.05 as compared with control; **P < 0.05 as compared with drug group; ***P < 0.05 as compared with RL
group
Fig. 3 Sections of ovary: there
are four parts in this picture. a The
control picture with less than
different follicles. b D group.
There is an increase in the growth
of different follicles compared to
CT. c RL group which shows that
an increase in growth of different
follicles more the D and CT
group. d The changes of NIRL
samples which have the most
increase in the number of different
follicles
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maximum LH level was for RL and the minimum was for
NIRL (Fig. 4b).
The increasing rate for LH level was as
RL > D > NIRL > CT
Estrogen hormone
Measurement of estrogen (E2) hormone, illustrated that its
increase differed significantly between CT and the other
groups. Compared to CT, the maximum increase was in D
samples (Fig. 4c) and the minimum was in RL and the growth
rate in D was proximately 1.11 and 1.05 times more than RL
and NIRL, respectively. Meanwhile, there was not much dif-
ference in the growth rate of E2 between D, RL, and NIRL
groups compared with CT group (Table 2). Also, according to
the result table, differences between D, RL, and NIRL groups
were not significant. So, the trend for E2 increase was as
D > NIRL > RL > CT
Progesterone hormone
There was significant difference between CT and D, between
CT and RL and between CT and NIRL. NIRL group had the
most decrease in progesterone (Pro) level and RL had the
least. There was not much difference between RL and D sam-
ples (Fig. 4d). Ratio of decrease for NIRL was approximately
0.76 times more than D and 0.69 times more than RL group
compared whit CT. Compared with D group, Pro decreased in
NIRL and increased in RL and CT groups while there was no
significant difference between D, RL and IRL groups
(Table 2). So, the decreasing rate of Pro can be written as
NIRL > D > RL > CT
Attenuation coefficient
The ln (I0/I) (primary and secondary intensity ratio) was plot-
ted to μx (x: thickness of skin). The attenuation coefficient is
obtained from slope of line and presented in the chart; the
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Fig. 4 Level of different
hormone. a An increase in level
of FSH in D, RL, and NIRL
groups compared to CT. The
maximum increase is for NIRL
group. b Level of LH increase by
laser and drug intervention in
which maximum increase is for
RL group although lowest
increase is in NIRL group. c An
increase in level of E2 in D, RL,
and NIRL groups compared to
CTwhile there is not little
difference between them. d
Changes level of Pro in D, RL,
and NIRL groups compared to
CT. It decreases by intervention
and the most decrease is in NIRL
group
Table 2 The parameter of hormone assay in ovary tissue
Parameters CT D RL NIRL
FSH (IU/L) 0.16875 ± 0.025174 0.15329 ± 0.052185 1.42025 ± 0.125126*,** 3.87733 ± 0.771480*,**,***
LH (IU/L) 0.03725 ± 0.011898 0.40557 ± 0.098978* 0.60867 ± 0.077197* 0.09457 ± 0.018313**,***
E2 (pg/mL)
f 11.900 ± 0.7000 18.917 ± 1.1453* 17.120 ± 0.8120* 18.086 ± 0.6588*
Pro (ng/mL)g 29.6300 ± 1.57000 17.3050 ± 1.56769* 19.1267 ± 2.64739* 13.1760 ± 0.41589*
Data are presented as mean ± SD
C control, D clomiphene drug, RL red laser intervention, NIRL near-infrared laser intervention, pg/mL 3.67 pmol/L, ng/mL 3.18 nmol/L
*P < 0.05 as compared with control; **P < 0.05 as compared with drug group; ***P < 0.05 as compared with RL group
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mean of measurement data is shown in Table 3. At the wave-
length of 630 nm, the attenuation coefficient was 1.1049,
based on the slope of the line and 1.0879, based on the calcu-
lated data for six samples, presented in the table. Additionally,
for the wavelength of 810 nm, based on the slope of the line
and data calculations for seven samples, it is 1.0299 and
1.0406, respectively (Fig. 5a, b).
Conclusion
This study investigated the effect of diode laser at two wave-
lengths (810 and 630 nm) on folliculogenesis cycle without
any surgery and compared the result with result of common
drug (clomiphene) application. In the first stage, lasers had
positive effect on macroscopic sexual behavior of rats. The
effect of both lasers was expected to be positive, but contrary
to this expectation, just near-infrared laser was significantly
better than drug. It could increase different follicles in
folliculogenesis cycle to produce oocyte by increasing the
level of useful sex hormones. Rats’ responses to near-
infrared laser (NIR group) in producing different follicles at
the end of folliculogenesis cycle were approximately 57%
positive, 29% neutral, and 14% negative. With red laser (RL
group) responses were 43% positive, 14% neutral, and 43%
negative. By drug intervention, they were 43 positive, 29%
neutral, and 14% negative. Although, the results varied for the
two laser modes, the method and statistical analyses that were
used in this study showed significant increasing results for
NIRL that certainly can be used in future studies for finding
a cure to ovarian negligence to produce more oocyte and treat
diseases caused by it like PCOS. Hence, this can be investi-
gated on rats with PCOS disease to find certain cure for that.
Compared with previous studies, like someone [9, 17, 20,
21, 23] in which laser was used as a complementary treatment,
the present study showed that diode laser with 810 nm wave-
length increases the function of folliculogenesis cycle to pro-
duce oocyte significantly more than drug.
In interpreting the findings of this study, it is important to
take its limitations into consideration. For instance, the exact
optical receptor and their optical potential on ovary tissue to
produce oocyte are not known. Also, ovary cannot be exactly
located due to its small size and its motion on mm range in the
body of rat. Additionally, while the result of study was signif-
icant and acceptable, the limited sample size bars definitive
conclusion. Furthermore, rats were kept in natural environ-
ment in the laboratory. However, many potentially important
exposure routes were not evaluated. Such exposures include
information about dietary intake, blood pressure, and the or-
gans under the skin of irradiated rats, as exposure may vary
due to different amounts of tissues such as fat.
The number of ovarian variable follicles in our study ex-
hibited different effects of treatments examined in this re-
search. Given that it is unknown if the ovaries were sick,
results are not definite; but based on previous studies [9, 20,
34], our results can be useful in the treatment of hypo activa-
tion of ovary.
Finally, this study investigated the direct effect of lasers in
near-infrared and red spectrum on producing different follicles
in folliculogenesis cycle and did not consider disorders in
Table 3 Attenuation coefficient
Wavelength (nm) I0 (w/cm
2) I (w/cm2) ln I0/I x ± 0.03 (mm) μ (1/mm)
630 32.3 7.8 1.4209 1.26 1.12770
32.7 11.2 1.0715 1.1 0.97410
31.6 8.7 1.2898 1.19 1.08387
34.2 8.3 1.416 1.28 1.10625
33.5 5.3 1.8438 1.51 1.22106
32.1 10.2 1.1465 1.13 1.01460
Mean of μ = 1.088 ± 0.152
810 202 50 1.3962 1.36 1.026618
216 67 1.1706 1.1 1.064182
188 61 1.1256 1.1 1.023273
216 55 1.3679 1.28 1.068672
219 67 1.1844 1.17 1.012308
195 64 1.1141 1.04 1.07125
218 69 1.1504 1.13 1.018053
Mean of μ = 1.037 ± 0.138
Measurement of six samples for red laser by 630 nm wavelength and seven samples for near-infrared laser by
810 nm wavelength
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folliculogenesis cycle to produce oocyte which can later be
investigated.
Despite these limitations, this study is an important contri-
bution to previous methods in the treatment of diseases caused
by negligence of the ovary. One of these diseases is polycystic
ovarian syndrome (PCOS) for which laser had been used as
complementary therapy [20, 34]. The aim of this research was
to propose the use of lasers autonomously, without any med-
ical and surgical intervention, in the treatment of ovarian neg-
ligence in adult women, unlike the past studies [9, 20].
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